Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > beta-NGF


Brief Information

Name:Nerve growth factor
Target Synonym:Nerve Growth Factor
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:13
Lastest Research Phase:NDA/BLA

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
BEF-M5213 Mouse Mouse Beta-NGF Protein, Tag Free (MALS verified)
BEF-H5214 Human Human Beta-NGF Protein, premium grade
ACRO Quality

Part of Bioactivity data

BEF-H5214-Cell-based assay

Human Beta-NGF Protein, premium grade (Cat. No. BEF-H5214) stimulates proliferation of TF-1 cells. The EC50 for this effect is 2.963 ng/mL (QC tested).


Immobilized Human Beta-NGF Protein, premium grade (Cat. No. BEF-H5214) at 1 μg/mL (100 μL/well) can bind Human TrkA (33-417), Mouse IgG2a Fc Tag (Cat. No. TRA-H5259) with a linear range of 1-16 ng/mL (QC tested).

Beta-NGF MALS images

The purity of Mouse Beta-NGF Protein, Tag Free (Cat. No. BEF-M5213) is more than 90% and the molecular weight of this protein is around 28-36 kDa verified by SEC-MALS.

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
DS-002 DS-002 Phase 2 Clinical Dartsbio Pharmaceuticals Ltd Pain; Cancer Pain Details
Antibodies to humanized nerve growth factor(Shenyang Sunshine Pharmaceutical) Phase 1 Clinical Shenyang Sunshine Pharmaceutical Co Ltd Cancer Pain Details
RGN-259 Fx peptide; TB4 16-38; RGN-457; Thymosin beta 4-16-38; Thymosin B4; RGN-352; RGN-259; RGN-137; Tβ4; TB4; GBT-201; GBT-101; Thymosin beta4 Phase 3 Clinical National Institutes Of Health Keratitis; Myocardial Ischemia; ST Elevation Myocardial Infarction; Myocardial Infarction; Graft vs Host Disease; Sjogren's Syndrome; Dry Eye Syndromes; Epidermolysis Bullosa; Pressure Ulcer; Epidermolysis Bullosa, Junctional; Varicose Ulcer; Diabetes Mellitus; Epidermolysis Bullosa Dystrophica Details
Fasinumab SAR-164877; MT-5547; R-475; REGN-475 Phase 3 Clinical Regeneron Pharmaceuticals Inc Abdominal Pain; Sciatica; Osteoarthritis, Knee; Back Pain; Osteoarthritis; Low Back Pain; Osteoarthritis, Hip Details
TNM-009 TNM-009; TNM009 Phase 1 Clinical Zhuhai Trinomab Pharmaceutical Co Ltd Cancer Pain; Pain Details
Neuroregenerative agents (iNtRON Biotechnology) Clinical Intron Biotechnology Nervous System Diseases Details
SMR-7694 SMR-7694; SMR7694 Phase 1 Clinical Sinobioway Biomedicine Co Ltd Osteoarthritis Details
MEDI-7352 MEDI-7352 Phase 2 Clinical Medimmune Chronic Pain; Diabetic Neuropathies; Osteoarthritis, Knee Details
EP-9001A EP-9001A Phase 1 Clinical Chengdu Youluo Biotechnology Co Ltd Bone metastases; Cancer Pain Details
Atinumab NG-101; ATI-355 Phase 2 Clinical Novartis Pharma Ag Spinal Cord Injuries; Gastroparesis; Diabetic Gastroparesis Details
N-Hexacosanol tCFA15; TAC-302 Phase 2 Clinical Meiji Seika Pharma Co Ltd Urinary Bladder, Underactive; Urinary Bladder, Overactive Details
Luvagrobart AK-115 Phase 1 Clinical Zhongshan Akeso Biopharma Co Ltd Pain; Cancer Pain Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message